Clinical Trials Browser

Phase 2 × Efficacy × niraparib × Clear all

NCT06237205 2024-02-01

Genome-Based Assessment of Niraparib (ZEJULA®) Efficacy in Advanced Solid TumorS With Homologous Recombination Deficiency

Phase 2 Not yet recruiting

Efficacy